Clinical Trials Browser

Leukoplakia, Leukokeratosis, Hereditary Mucosal

Colorectal Neoplasms

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Carcinoma, Basal Cell, Skin Neoplasms

Glioblastoma, Glioma

Squamous Intraepithelial Lesions, HIV Infections

Uterine Cervical Dysplasia

Keratosis, Actinic

Glioblastoma

Squamous Cell Carcinoma of Head and Neck

Uterine Cervical Neoplasms, Neoplasm Metastasis, Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Papillomavirus Infections

Keratosis, Actinic

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

Bone Neoplasms, Sarcoma

Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Dysplasia

Carcinoma, Basal Cell

Mycosis Fungoides

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Uterine Cervical Dysplasia

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Vulvar High Grade Squamous Intraepithelial Lesion (HSIL)

Carcinoma, Basal Cell

Keratosis, Actinic

Astrocytoma, Glioblastoma, Glioma

Carcinoma, Basal Cell

Carcinoma, Basal Cell

Keratosis, Actinic

Keratosis, Actinic

Condylomata Acuminata

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Keratosis, Actinic

Breast Neoplasms

Breast Neoplasms

Uterine Cervical Dysplasia

Patient Satisfaction

Uterine Cervical Neoplasms

Keratosis, Actinic

Condylomata Acuminata, Sexually Transmitted Diseases, Virus Diseases, Papillomavirus Infections

Keratosis, Actinic

Condylomata Acuminata

Keratosis, Actinic

Clinical Trials

Topical Imiquimod Treatment of Oral Dysplasia

Immunotherapy for Recurrent Ependymomas in Children Using Tumor Antigen Peptides With Imiquimod

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

A Phase 1 Dose-escalation Study of UGN-301 in Patients With Recurrent Non-muscle Invasive Bladder Cancer (NMIBC)

SONIB

Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma

INTERCEPT-H3

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

Topical Fluorouracil and Imiquimod in Treating Patients With High-Grade Cervical Intraepithelial Neoplasia

Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%

Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme

Neoadjuvant Imiquimod Immunotherapy for Oral Cancer

HPV-VIM

Comparing Immune Responses to Topical Imiquimod

ANCHOR

Dendritic Cell Vaccine for Children and Adults With Sarcoma

Vaccination of Patients With Ovarian Cancer With Dendritic Cell/Tumor Fusions With Granulocyte Macrophage Colony-stimulating Factor (GM-CSF) and Imiquimod

Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)

REDT-BCC

Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides

CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults

Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL

PRedICT-TOPIC

Vaccine Therapy With or Without Imiquimod in Treating Patients With Grade 3 Cervical Intraepithelial Neoplasia

Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3)

Treatment of Nodular Basal Cell Carcinoma (BCC) With Imiquimod 5% Cream After Curettage

PACKS

NY-ESO-1 Protein Vaccine With Imiquimod in Melanoma (Adjuvant Setting)

Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma

Aldara for the Treatment of Large and/or Multiple sBCC

A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma

A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ

A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatment of Actinic Keratoses in Organ Transplant Recipients

Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts

Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions

Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients

LEIDA

LEIDA 2

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Toll-like Receptor (TLR) 7 Agonist, Cyclophosphamide, and Radiotherapy for Breast Cancer With Skin Metastases

Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer

Comparison of Treatment of Cervical Intraepithelial Lesions With Imiquimod or LLETZ

PITVIN

Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

Efficacy and Tolerability of Topical LFX453 for External Genital Warts

Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis

AdAM

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies